Technical Analysis for CATX - Perspective Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| NR7 | Range Contraction | 4.55% | |
| Lower Bollinger Band Walk | Weakness | 4.55% | |
| Stochastic Reached Oversold | Weakness | 4.55% | |
| Inside Day | Range Contraction | 4.55% | |
| Wide Bands | Range Expansion | 4.55% | |
| Below Lower BB | Weakness | 4.55% |
| Alert | Time |
|---|---|
| 10 DMA Resistance | 1 day ago |
| 60 Minute Opening Range Breakout | 1 day ago |
| Up 10% | 1 day ago |
| Up 1 ATR | 1 day ago |
| Gap Up Closed | 2 days ago |
Get this analysis on your stocks daily!
- Earnings date: 02/28/2024
Perspective Therapeutics, Inc. Description
Perspective Therapeutics, Inc., formerly known as Isoray, Inc., is a medical technology and radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body. The Company is the sole producer of Cesium-131 brachytherapy seeds and has a proprietary technology that utilizes the isotope lead-212 to deliver powerful alpha radiation specifically to cancer cells via specialized targeting peptides. The Company is also developing complementary imaging diagnostics that incorporate the same targeting peptides which provide the opportunity to personalize treatment and optimize patient outcomes. This “theranostic” approach enables the ability to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity associated with many other types of cancer treatments.
Classification
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Biotechnology Cancer Clinical Medicine Cancer Treatment Treatment Of Cancer Imaging Medical Technology Radiation Radiation Therapy Medical Physics Personalized Medicine Brachytherapy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.905 |
| 52 Week Low | 0.205 |
| Average Volume | 6,169,878 |
| 200-Day Moving Average | 0.75 |
| 50-Day Moving Average | 1.53 |
| 20-Day Moving Average | 1.62 |
| 10-Day Moving Average | 1.49 |
| Average True Range | 0.16 |
| RSI (14) | 39.76 |
| ADX | 26.53 |
| +DI | 16.69 |
| -DI | 23.05 |
| Chandelier Exit (Long, 3 ATRs) | 1.43 |
| Chandelier Exit (Short, 3 ATRs) | 1.77 |
| Upper Bollinger Bands | 1.94 |
| Lower Bollinger Band | 1.30 |
| Percent B (%b) | 0.13 |
| BandWidth | 39.55 |
| MACD Line | -0.05 |
| MACD Signal Line | 0.00 |
| MACD Histogram | -0.0445 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.67 | ||||
| Resistance 3 (R3) | 1.67 | 1.59 | 1.62 | ||
| Resistance 2 (R2) | 1.59 | 1.51 | 1.58 | 1.60 | |
| Resistance 1 (R1) | 1.48 | 1.47 | 1.44 | 1.48 | 1.59 |
| Pivot Point | 1.40 | 1.40 | 1.38 | 1.39 | 1.40 |
| Support 1 (S1) | 1.29 | 1.32 | 1.25 | 1.29 | 1.17 |
| Support 2 (S2) | 1.21 | 1.28 | 1.20 | 1.16 | |
| Support 3 (S3) | 1.10 | 1.21 | 1.14 | ||
| Support 4 (S4) | 1.10 |
